Header Logo

Connection

LUKAS SIMON to Trastuzumab

Back to Details
This is a "connection" page, showing publications LUKAS SIMON has written about Trastuzumab.
LUKAS SIMON
Connection Strength
0.149
Trastuzumab
  1. Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer. Mol Cancer Res. 2019 11; 17(11):2318-2330.
    View in: PubMed
    Score: 0.149
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.